November 16-17, 2021 (1:00-6:00 p.m. ET)
Fertility and Infertility Branch (FIB), Gynecologic Health and Disease Branch (GHDB), and Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Division of Extramural Research (DER), NICHD
This workshop aims to stimulate a transdisciplinary discussion on the state-of-the-art of tissue-construct manufacturing using 3D printing of biological, cellular, and tissue-based products (a.k.a., bioprinting) and regenerative medicine in the context of obstetric, gynecologic, and pediatric applications. The goal of this virtual event is to answer the following broad questions surrounding the research on 3D bioprinting and regenerative medicine:
- What is the current state of knowledge?
- What are the key gaps and roadblocks that need to be addressed in the field?
- What could we do to move the field forward?
This workshop will bring together multidisciplinary experts and broad thinkers, including regulatory and manufacturing experts, 3D bioprinting and tissue-construct scientists, and bioengineers, as well as scientists and clinicians in regenerative medicine research. Participants will engage in active discussions about possible future research directions, resources, and applications of these technologies.
Individuals who need reasonable accommodations to participate in this activity should contact Liza Cook at firstname.lastname@example.org at least 5 days in advance.
Share Your Ideas and Feedback
As a corollary to the workshop, NICHD also launched an Advancing Bioprinting and Regenerative Medicine Solutions for Obstetric, Gynecologic, and Pediatric Applications crowdsourcing website . This IdeaScale campaign aims to spark conversations among diverse stakeholders about priority areas for future research, technology development, and resources in the 3D bioprinting and regenerative medicine fields.
Stakeholders can comment on five existing questions or add their own ideas to the conversation. Participation is not anonymous; you must register with a valid email to access the campaign, and only those registered are permitted to provide feedback and enrich the discussion. Please note that ideas discussed through IdeaScale are not an obligation by NICHD to fund or pursue research; instead, suggestions will provide useful insight into the needs of the bioprinting and regenerative medicine research communities.
This campaign will remain open for several weeks after the workshop concludes.
Learn more about the workshop: https://cvent.me/N9X2lR
Dr. Clara Cheng, FIB, DER, NICHD
Dr. Donna Mazloomdoost, GHDB, DER, NICHD
Dr. Antonello Pileggi, OPPTB, DER, NICHD